SPY764.73+0.10%QQQ743.60+0.21%BTC/USD84,862.20+0.01%DIA508.66+0.01%GLD383.30+0.14%TLT77.70−0.01%
Benzinga

Martin Shkreli

Martin Shkreli is a former pharmaceutical executive who gained notoriety in 2015 for dramatically increasing the price of the antiparasitic drug Daraprim. He was the CEO of Turing Pharmaceuticals and previously founded hedge funds MSMB Capital and MSMB Healthcare. In 2017, Shkreli was convicted of securities fraud unrelated to the drug pricing controversy and sentenced to prison. His actions sparked widespread debate over pharmaceutical pricing and corporate ethics.

Martin Shkreli Shorts Micron 2 Months After Saying ‘I Like Micron’: ‘If Memory Prices Drop, It’s All Over’
Martin Shkreli Shorts Micron 2 Months After Saying ‘I Like Micron’: ‘If Memory Prices Drop, It’s All Over’
QUICK SPARK: Pharma Bro Martin Shkreli Says Ultragenyx Should Be M&A Target
QUICK SPARK: Pharma Bro Martin Shkreli Says Ultragenyx Should Be M&A Target
Pharma Bro Admits 'Playing Around' With MRNA Short At $80 Before it Exploded 177% Following Cancer Vax Trials— ‘I Bet You a Bunch of People Got Fired’
Pharma Bro Admits 'Playing Around' With MRNA Short At $80 Before it Exploded 177% Following Cancer Vax Trials— ‘I Bet You a Bunch of People Got Fired’
QUICK SPARK: Pharma Bro Martin Shkreli Says Ultragenyx Should Be M&A Target
QUICK SPARK: Pharma Bro Martin Shkreli Says Ultragenyx Should Be M&A Target
Pharma Bro Admits 'Playing Around' With MRNA Short At $80 Before it Exploded 177% Following Cancer Vax Trials— ‘I Bet You a Bunch of People Got Fired’
Pharma Bro Admits 'Playing Around' With MRNA Short At $80 Before it Exploded 177% Following Cancer Vax Trials— ‘I Bet You a Bunch of People Got Fired’
CoreWeave Is a 'Short' — Martin Shkreli Lays Out His Bear Case
CoreWeave Is a 'Short' — Martin Shkreli Lays Out His Bear Case
JPMorgan Was a Broker to AI Hedge Fund Situational Awareness— Now Jamie Dimon Is Warning About Hidden Leverage Risk: 'Margin Debt Is the Highest...'
JPMorgan Was a Broker to AI Hedge Fund Situational Awareness— Now Jamie Dimon Is Warning About Hidden Leverage Risk: 'Margin Debt Is the Highest...'

Martin Shkreli Recent News

QUICK SPARK: Martin Shkreli Shorts Hims & Hers Stock, Says 'Peptides Are Fake Medicine'
QUICK SPARK: Martin Shkreli Shorts Hims & Hers Stock, Says 'Peptides Are Fake Medicine'
Martin Shkreli shorts Hims & Hers stock, calling its peptides fake medicine.
OPEN CEO Takes $1 Salary As $741 Million Tesla-Style Pay Package Bets On A Housing Market Turnaround
OPEN CEO Takes $1 Salary As $741 Million Tesla-Style Pay Package Bets On A Housing Market Turnaround
Opendoor's CEO makes $1 in cash and $741M in stock alignment, a performance package echoing Tesla's legendary pay milestones.
Martin Shkreli Predicts Meta Could Buy Anthropic In A 'Down Exit' As Claude Maker Eyes IPO
Martin Shkreli Predicts Meta Could Buy Anthropic In A 'Down Exit' As Claude Maker Eyes IPO
Martin Shkreli predicts Meta will acquire Anthropic in a "down exit" amid AI backlash, stealth nerfing outrage, and a risky $965B IPO filing.
Martin Shkreli Accuses IONQ Of Making Wild Bitcoin Mining Claims: 'They Were Lying'
Martin Shkreli Accuses IONQ Of Making Wild Bitcoin Mining Claims: 'They Were Lying'
Martin Shkreli, also known as “Pharma Bro,” has escalated his stand against quantum computing firm IONQ Inc.
Martin Shkreli Says Elizabeth Warren Shoots From The Hip And Is Wrong About Tesla, Disney And Palantir Paying Zero Taxes: 'You Don't Know Facts'
Martin Shkreli Says Elizabeth Warren Shoots From The Hip And Is Wrong About Tesla, Disney And Palantir Paying Zero Taxes: 'You Don't Know Facts'
Martin Shkreli pushed back on Elizabeth Warren's claim that major companies including Tesla, Disney, Palantir paid $0 federal income tax.
Why Are Strategy Shares Seesawing On Tuesday?
Why Are Strategy Shares Seesawing On Tuesday?
Strategy Inc. (NASDAQ:MSTR) saw its stock price slide before heading back up during Tuesday's trading session.
Martin Shkreli, AOC Agree Kalshi Has A Problem
Martin Shkreli, AOC Agree Kalshi Has A Problem
Shkreli and AOC agree that Kalshi hasn't gone far enough in policing who can trade on its event markets.
Martin Shkreli Shares AI Traffic Data That Shows ChatGPT, Gemini Lead The Way In User Minutes, But Gets Called Out For Being 'Pretty Deceptive'
Martin Shkreli Shares AI Traffic Data That Shows ChatGPT, Gemini Lead The Way In User Minutes, But Gets Called Out For Being 'Pretty Deceptive'
Investor Martin Shkreli, popularly referred to as the "Pharma Bro," released the traffic data of leading AI websites while highlighting the stark disparities in the usage of popular chatbots.
Martin Shkreli's Biotech Short Position Is Blowing Up As Stock Soars 440%: Momentum Score Spikes
Martin Shkreli's Biotech Short Position Is Blowing Up As Stock Soars 440%: Momentum Score Spikes
Investor Martin Shkreli's big biotech short position is blowing up after the stock's monumental rally over the past week.
Martin Shkreli Warns Elizabeth Warren And Zohran Mamdani Policies Would Make US Stock Returns Resemble France, Japan's Dismal Performance
Martin Shkreli Warns Elizabeth Warren And Zohran Mamdani Policies Would Make US Stock Returns Resemble France, Japan's Dismal Performance
While comparing U.S. equity market returns over the past 35 years with those of France and Japan, investor Martin Shkreli issued a sharp warning regarding the growing influence of progressive lawmakers on the nation's economy.
Martin Shkreli Takes Aim At Capricor — Stock Sinks
Martin Shkreli Takes Aim At Capricor — Stock Sinks
Capricor Therapeutics stock plummets after Martin Shkreli announces he is shorting the stock.
'Pharma Bro' Martin Shkreli Begs 'Wannabe' Finance Influencers To Learn Basics As China, Malaysia Crack Down On 'Finfluencers'
'Pharma Bro' Martin Shkreli Begs 'Wannabe' Finance Influencers To Learn Basics As China, Malaysia Crack Down On 'Finfluencers'
Martin Shkreli, former hedge fund manager known as Pharma Bro, scolded finance personalities for not understanding accounting and defending Nvidia's Q3 performance, which saw record revenue of $57.0B. He has previously argued that the company is undervalued and backed their investment in OpenAI. NVDA stock finished down 3.15% but has gained 23.82% in the last year.
Shkreli's Shorts Up 600% As Quantum Stocks Tank
Shkreli's Shorts Up 600% As Quantum Stocks Tank
Martin Shkreli celebrates 600% gains on his quantum stock short bets.
Beyond Meat Q3 Preview: Investors Hope Delayed Report Shows Growth, Future Plans
Beyond Meat Q3 Preview: Investors Hope Delayed Report Shows Growth, Future Plans
Beyond Meat reports Q3 results Monday after a short delay. Here's the key items investors should know.
Sarepta Stock Dumps: Pharma Bro Martin Shkreli Still Likes It
Sarepta Stock Dumps: Pharma Bro Martin Shkreli Still Likes It
Enough though Sarepta shares are crashing, "Pharma Bro" Martin Shkreli says he still likes the stock. 
Martin Shkreli Blasts Trump's Move To Buy Shares Of Quantum Computing Companies For the US Government, Suggests The President Should Do This Instead
Martin Shkreli Blasts Trump's Move To Buy Shares Of Quantum Computing Companies For the US Government, Suggests The President Should Do This Instead
Investor Martin Shkreli, popularly known as "Pharma Bro," is criticizing President Donald Trump's latest decision to acquire equity stakes in quantum computing stocks.
Latest Beyond Meat Short-Seller? Martin Shkreli, Of Course
Latest Beyond Meat Short-Seller? Martin Shkreli, Of Course
Martin Shkreli shorts Beyond Meat stock as it ripped higher Wednesday.
Quantum Stock Rally Leaves Shkreli's Short 'Pretty F***n' Far From Okay'
Quantum Stock Rally Leaves Shkreli's Short 'Pretty F***n' Far From Okay'
Shkreli ventson X, saying, "I'm pretty fkin' far from okay," in reference to the squeeze on his quantum short positions.​
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved